[Invasive pneumoccal disease in children in Oslo 1998-2004]

Lin Vigdis Brauteset1, Ernst Arne Høiby, Gaute Syversen

  • 1Barneklinikken Ullevål universitetssykehus 0407 Oslo. linvigdis.brauteset@ulleval.no

Insights

Invasive pneumococcal disease (IPD) is a serious threat to children. Vaccination offers significant protection against IPD, preventing many cases and reducing mortality in pediatric populations.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Vaccinology

Context:

  • Invasive pneumococcal disease (IPD) poses a significant public health challenge in children, contributing to substantial morbidity and mortality.
  • Understanding the epidemiology and characteristics of IPD is crucial for effective prevention and treatment strategies.

Purpose:

  • To investigate the epidemiology, predisposing factors, clinical presentation, antimicrobial resistance, and outcomes of IPD in Norwegian children.
  • To assess the theoretical impact and coverage of the 7-valent conjugate pneumococcal vaccine (PCV7) on identified IPD cases.

Summary:

  • A retrospective analysis of 68 children under 16 with IPD revealed that 31 had predisposing factors, and all six deaths occurred in this subgroup.
  • Antimicrobial susceptibility testing showed high susceptibility to benzyl penicillin, with some resistance to erythromycin. PCV7 could have potentially covered serotypes in 35% of cases.
  • While PCV7 showed limited coverage for the specific serotypes causing IPD in this cohort, vaccination remains a key strategy for preventing pneumococcal disease.

Impact:

  • This study highlights the severity of IPD in children and underscores the critical role of pneumococcal vaccination in disease prevention.
  • Findings provide valuable data for public health initiatives and inform vaccination policies aimed at reducing the burden of IPD in pediatric populations.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: